EUR 309.30 For Business Accounts Only

Pharmaceuticals in Australia

Summary
Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Australia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Australia
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Australia pharmaceuticals market with five year forecasts

Synopsis
Essential resource for top-line data and analysis covering the Australia pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons To Buys

- What was the size of the Australia pharmaceuticals market by value in 2016?
- What will be the size of the Australia pharmaceuticals market in 2021?
- What factors are affecting the strength of competition in the Australia pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitiors in Australia's pharmaceuticals market?

Key Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2016 annual average exchange rates.
- The Australian pharmaceuticals market had total revenues of $22.9bn in 2016, representing a compound annual growth rate (CAGR) of 1.9% between 2012 and 2016.
- Factors driving growth in Australia’s pharmaceuticals are similar to many other developed markets, including an increasingly elderly population and its associated disease burden, along with well-defined regulatory guidelines and the rising prevalence of non-communicable diseases due to an increasingly sedentary way of life.
- Alternative treatments pose a serious substitution threat in Australia, to the distaste of the medical profession. The Medical Journal of Australia found controversial and unproven treatments for menopause are being used by nearly 500,000 Australian women, most of who were directed towards the treatments by doctors.